Research and Markets: The Global Pharmaceutical Industry Revenue is Forecasted to Reach an Estimated $1,226.0 Billion by 2018, With Good Growth over the Next Five Years

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/kzdpm6/global) has announced the addition of the "Global Pharmaceutical Industry 2013-2018: Trend, Profit, and Forecast Analysis" report to their offering.

The industry is expected to register growth led by an aging population, changing lifestyles, hectic daily activities, unhealthy eating habits, and increasing incidence of chronic diseases across the entire global population, providing growth opportunities for the industry players.

The global pharmaceutical market faces major challenges from increasing investment and strict regulation. Changing lifestyles and the fast socio-demographic shift due to urbanization in both developed and growth markets globally are expected to drive the demand. The ability to create new technology and innovative drugs is a key driver for success in this market.

North America is projected to lead the pharmaceutical industry. The vaccine industry is expected to record the highest growth during the forecast period. The ROW industry is expected to witness the highest growth during 2013-2018. Government initiatives in Brazil to encourage drug industries by providing free pricing policies and special financial investment options will attract the industry players. APAC holds good growth potential for the future.

This study provides an overview of the global pharmaceutical industry by tracking 13 market segments of that industry in four geographic regions. Thus, a total of 52 segments of the global pharmaceutical industry are tracked. The report studies manufacturers of bone, respiratory, immunology and dermatology, cardiovascular, diabetes & obesity, urinary/kidney diseases, gastrointestinal, neurosciences, infectious diseases, ophthalmology, oncology, women's health/endocrine, vaccines, consumer health/OTC, and others providing a five-year (2007-2012) annual trend analysis that highlights market size, profit and cost structure for NA, Europe, APAC, and ROW. The report also provides a forecast, addressing market opportunities for the next five years (2013-2018) for each of these regions.

Features and Scope of this Report:

To make any investment or strategic decision, you need adequate and timely information. This market report fulfills this core need. Some of the features of this market report are:

- Industry size estimates in terms of (US $) value by regions and by segments

- Global pharmaceutical industry annual trend (2007-2012) and forecast (2013-2018)

- Porter's Five Force analysis

- New product launch, merger and acquisition activity in global pharmaceutical industry

- Quarterly demand trend (Q1 2011-Q4 2012) and forecast analysis (Q1 2013-Q4 2014) for pharmaceutical industry analysis

- Gross and net profit trends in the global pharmaceutical industry

- Cost structure trend in the global as well as regional pharmaceutical industry

For more information visit http://www.researchandmarkets.com/research/kzdpm6/global.

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals